Signature formulation · Daily Wellness
A next-generation multivitamin–postbiotic complex inspired by Japanese cherry blossom and built for a complete daily wellness ritual.
Why it was created
SAKULORA™ brings together two ideas that rarely meet in one product: a comprehensive daily micronutrient base and an innovative Japanese postbiotic discovered in shidare-zakura flowers.
The name combines SAKURA—a Japanese symbol of renewal—with FLORA, the living ecosystem associated with inner balance. The result is a formula that feels distinctly Japanese while answering a practical daily need.
Process · a blossom-derived postbiotic
The story centres on the selected bacterial strain: its floral origin, heat inactivation and place within a micronutrient formula.
Explore ingredient evidenceThe selected bacterial strain originates from shidare-zakura blossoms.
Illustrative ingredient study. Shapes and movement are simplified; product evidence is reviewed separately.
Formula architecture
Inside the formula · per 4-tablet daily serving
Heat-inactivated Lacticaseibacillus paracasei shidare; equivalent to 50 billion cells before inactivation.
From shell-derived calcium carbonate.
As ascorbic acid.
As ferric pyrophosphate.
As magnesium oxide.
A considered daily level within the complete micronutrient platform.
As cholecalciferol.
Zinc 8 mg, copper 0.9 mg, iodine 150 μg and selenium 55 μg.
One formula · several complementary layers
The formula is deliberate: a broad vitamin-and-mineral base is paired with the signature cherry-blossom postbiotic in one practical daily tablet system.
Ingredient evidence library
Oryza identifies SAKULORA™ as Lacticaseibacillus paracasei shidare, discovered through screening of lactic-acid bacteria collected from Japanese cherry blossoms.
A 2026 peer-reviewed article reports a randomised, double-blind, placebo-controlled study in 44 healthy adults using 50 mg daily. This evidence relates to the ingredient—not the complete multivitamin formula.
The ingredient dossier includes gastrointestinal, immune, beauty and femcare research. Study type varies, and preclinical findings must not be presented as confirmed benefits of the finished product.
A 12-month double-blind, placebo-controlled trial assigned 198 women aged 25–45 with vitamin D insufficiency to placebo or 400–2400 IU of vitamin D₃ daily and measured serum 25-hydroxyvitamin D and parathyroid hormone. SAKULORA™ provides 600 IU daily; the study did not test the finished formula.
Professional product data
Current Japanese composition: Reduced maltose syrup (manufactured in Japan), shell-derived calcium carbonate, hydrolysed starch, powdered cellulose, vitamin C, ferric pyrophosphate, magnesium oxide, calcium stearate, silicon dioxide, niacinamide, hydroxypropyl cellulose, calcium pantothenate, shellac, calcium lactate, vitamins B₆, B₁ and B₂, β-carotene, folic acid, vitamin D₃, vitamin B₁₂, yeast-derived zinc, copper, iodine and selenium, and heat-inactivated Lacticaseibacillus paracasei. Exact declaration must follow the approved destination-market label.
Take four tablets daily with water according to the current Japanese directions. Store away from high temperature, humidity and direct sunlight. Not recommended for young children. Consult a qualified healthcare professional before use during pregnancy or breastfeeding, when taking medication, under medical supervision, or where nutrient intake requires individual assessment. Keep out of reach of children and follow the market-specific label.
Japanese quality & provenance
Developed and manufactured in Japan with a dossier-led approach for international professional review. Product specifications and market documentation are provided through Yotsuba Japan’s official partner network, subject to destination-market requirements.
Frequently asked
No. Its signature Lacticaseibacillus paracasei shidare ingredient is heat-inactivated. It is therefore positioned as a postbiotic ingredient rather than a live probiotic culture.
The formula combines a broad vitamin-and-mineral platform with 50 mg of SAKULORA™ postbiotic per daily serving. The differentiator is the complete architecture, not a single vitamin in isolation.
The current Japanese dossier indicates four tablets daily with water. Always follow the directions on the approved market-specific label.
Its portfolio positioning is women’s daily wellness, but suitability depends on individual needs, diet, life stage and professional guidance. Market-specific positioning must follow local regulations.
No. The research shown relates to the SAKULORA™ postbiotic ingredient or vitamin D₃ included in the formula. It explains the scientific rationale and must not be interpreted as proof that the complete finished formula reproduces every reported outcome.
Food supplement · Not a medicine
Product information is educational and intended for professional portfolio review. It is not medical advice and is not intended to diagnose, treat, cure or prevent disease. Suitability, permitted claims and labelling must be assessed for each destination market.SAKULORA™